Introduction
The membranous transport of several physiological regulators of pulmonary cell function and lung fluid homoeostasis has been suggested to be facilitated by members of the organic cation transporter (OCT) family encoded by the SLC22A1-A3 genes (Salomon and Ehrhardt, 2012) . In mammals, OCT1, OCT2 and OCT3 translocate small (i.e. < 500 Da) organic cations with broad, overlapping affinities for endogenous substrates, such as choline, acetylcholine and monoamine neurotransmitters, as well as a variety of xenobiotics (Pelis and Wright, 2014) . OCTs operate electrogenically and independent of sodium gradients and transport in both directions following the substrates' concentration gradient (Ciarimboli, 2010; Koepsell et al., 2007) . OCT physiology in tissues such as the liver, gut and kidneys has by and large been well characterised (Nies et al., 2011) , nonetheless, the lungs remain somewhat understudied in this regard. Moreover, OCT expression data concerning the respiratory epithelium is often limited to gene or PCR-based in vitro studies (Bleasby et al., 2006; Courcot et al., 2012; Endter et al., 2009; Mukherjee et al., 2012) and only a small number of reports show OCT immunocytochemistry or indeed transporter function (Lips et al. 2005; Macdonald et al., 2013; Nakanishi et al., 2013) . Very recently, it has been shown by our group that β 2 agonists interact with OCT at the lung epithelium (Salomon et al., 2015) , however, the clinical relevance of these findings are not fully understood to date.
One confounding factor for this scarcity of data is the limited availability of appropriate in vitro models for the study of ion and solute transport in the human distal lungs (Kim et al., 2001) . Whilst freshly isolated human alveolar or 4 bronchiolar epithelial cells in primary culture remain the gold standard for any kind of transport study involving the respiratory zone, limited availability of tissue, ethical restrains in certain countries and often economical and/or logistical shortcomings, hamper the use of human tissue. Accordingly, a number of cell lines has been utilised in ion and solute transport experiments, focusing on the respiratory epithelium, including the adenocarcinoma cell line, A549 (Sporty et al., 2008) . Although A549 cells have been used as an in vitro model by many investigators, it should be noted that this cell line does not form tight monolayers of polarised cells (Forbes and Ehrhardt, 2005) , an essential feature for transmonolayer transport studies. The cell lines 16HBE14o-, VA10, Nuli-1 and Calu-3, all of trachea-bronchial epithelial origin, have functional tight junctions and thus generate reasonable transepithelial electrical resistance (TEER) values indicative of polarised mucosal barriers (Buckley et al., 2011) .
The cell line NCI-H441 also forms tight monolayers and exhibits features of both alveolar (i.e. type II cell) and bronchiolar (i.e. club cell) epithelial phenotype (Hermanns et al., 2005; Salomon et al., 2014) .
It was the aim of this study to determine OCT activity in a number of commonly used cell lines of human respiratory epithelial origin and to compare the obtained data to freshly isolated human alveolar epithelial cells in primary culture, in order to identify a suitable in vitro model for biopharmaceutical and physiological organic cation transport studies at the air-blood barrier. (Demling et al., 2006; Daum et al., 2012) . Purified type II cells were seeded at a density of 600,000 cells/cm 2 on collagen/fibronectin-coated plastics using complete small airways growth medium (SAGM; Lonza, Verviers, Belgium) supplemented with 1% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin. Primary cell monolayers were used after transdifferention into an alveolar type I-like (ATIlike) phenotype, following at least one week of culture.
Uptake studies
Cells were grown to confluent monolayers on 24-well plates for at least 5 At the relevant time points, the uptake was stopped by washing cell monolayers three times with ice-cold buffer and 400 µl of 1N NaOH was added to permeabilise the cells for at least 12 h, before 400 µl of 1N HCl was used for neutralisation of the cell lysate. Five-hundred microlitres of lysate was used to measure the cell-associated radioactivity in a liquid scintillation counter (Tri Carb TR2100 Packard Scintillation Counter, Dublin, Ireland Biotechnology) or scrambled control siRNA (AllStars, Qiagen) were mixed, incubated at room temperature for 5 -10 min and added drop wise to the cells.
The concentrations were chosen according to the manufacturer's guidance and did not cause significant toxicity after transfection with any of the siRNA types.
Cells were then incubated at 37°C for 24 h, before the medium was changed back to the standard cell culture medium. After 24, 48 and 72 h, cell monolayers were lysed in cell extraction buffer containing protease inhibitors (Invitrogen, Karlsruhe, Germany). Protein sample concentration was determined with the DC Protein Assay kit and used for Western blot analysis. Uptake studies were carried out with cells after 4 days of culture, i.e. 72 h post transfection.
Immunoblotting
Lysis of A549 cells was performed on ice in cell extraction buffer (Invitrogen)
containing protease inhibitors (Sigma-Aldrich). Cell samples were sonicated twice for 10 s and then the lysate was centrifuged (10,000g at 4°C) for 20 min.
The total protein amount was determined by DC Protein Assay kit using bovine serum albumin (BSA) as standard. Samples were standardised to equal protein concentrations, loading buffer was added and the mixture was heated up to The time-dependent uptake was fitted using GraphPad Prism 5. One binding site was assumed and fitting was corrected for non-specific binding.
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To calculate the kinetic parameters of TEA uptake, the initial uptake rates were fitted to Equation 2 by means of non-linear least-squares regression analysis using WinNonlin (Pharsight, Sunnyvale, CA).
where ν is the initial uptake rate of the substrate (nmol/min×mg protein), s is the substrate concentration in the medium (µM), K m is the Michaelis-Menten constant (µM), and V max is the maximum uptake rate (nmol/min×mg protein).
Results are expressed as means ± SD unless otherwise stated. Statistical significance of differences between groups was determined by one-way analysis of variance (ANOVA), followed by the modified Fisher's least squares difference method. All experiments were carried out at least in triplicate. 
Results

Time course of TEA uptake
The time courses of TEA uptake into human lung epithelial cell monolayers is shown in Figure 1 . In ATI-like cells, the cell/medium ratio levelled off after 10 min of incubation and reached a maximal value of 6.08 ± 1.84 µl/mg protein after 30 min (Fig. 1a) . Similar trends were observed in NCI-H441 (Fig. 1c) and Calu-3 (Fig. 1d) cells, albeit the maximum cell/medium ratios at 30 min were significantly lower at 1.78 ± 0.30 µl/mg protein and 1.03 ± 0.08 µl/mg protein, respectively. TEA uptake was found to be linear in the case of A549 cells (Fig.   1b ), reaching a cell/medium ratio of 8.40 ± 1.43 µl/mg protein after 30 min.
Kinetic analysis of TEA uptake
In A549 cell monolayers, TEA uptake was, at least partially, saturable (Fig. 2a) .
Eadie-Hofstee transformation of these data (Fig. 2d) (Fig. 2d) . On the contrary, when TEA uptake was studied in NCI-H441 and Calu-3 epithelial monolayers, no saturation was observed in the concentration range studied (Fig. 2b, c) .
RNA interference studies in A549 cells
To investigate the molecular identity of the transporter(s) involved in TEA uptake at the air-blood barrier, knockdown of OCT1, OCT2 and OCT3 cells was carried out in A549 using transporter-specific siRNA. Uptake studies were performed 3 days post transfection and in parallel, protein expression levels were determined from the same batches of cells (see Supplemental Figure) . All experiments were performed in untreated, mock-transfected and OCT siRNAtransfected A549 cells. No significant differences in transporter expression and TEA uptake were observed between untreated and mock-transfected A549 cells (data not shown). OCT protein levels were reduced by approximately 30% (OCT1), 85% (OCT2) and 45% (OCT3), in comparison to the relevant mocktransfected controls (Fig. 3a-c) . As shown in Fig. 3d -f, RNAi targeting OCT1 and OCT2 significantly inhibited TEA uptake to 52.5 ± 3.2% and 50.4 ± 8.6%, respectively, whereas knockdown of OCT3 had a much less pronounced effect of 84.6 ± 8.3%.
Effect of pharmacological OCT inhibition on TEA uptake
Several different modulators of OCT activity were chosen according to their inhibitory potential (Nies et al., 2011) and their effects were corrected for nonspecific binding at 4°C (Fig. 4) .
Amantadine (1 mM) only marginally inhibited TEA uptake into ATI-like cells (i.e.
85.8 ± 14.5% of control), whereas in A549 cells, uptake was reduced to 24.6 ± 1.8% of control. In NCI-H441 and Calu-3 values of 50.8 ± 32.9% and 57.4 ± 15.0% were obtained (Fig. 4a) . The effect of corticosterone (500 µM) on ATI-like cells was much more pronounced (i.e. 19.3 ± 10.2%); a value comparable to what was seen in A549 cells (i.e. 12.5 ± 1.8%). NCI-H441 and Calu-3 cells were less affected by the steroid, with TEA uptake being reduced to 57.7 ± 15.9%
(HCI-H441) and 44.5 ± 0.3% (Calu-3) (Fig. 4b) . Decynium-22 (500 µM) strongly reduced TEA uptake in ATI-like (18.6 ± 9.9%), A549 (0.0 ± 0.8%) and NCI-H441
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(6.1 ± 4.7%) cells, whereas no inhibition was measured in Calu-3 cells (97.0 ± 26.9%) (Fig. 4c) . Very similar effects were noticed when quinidine was used:
ATI-like (1.5 ± 1.4%), A549 (0.0 ± 0.8%) and NCI-H441 (7.2 ± 6.8) cells showed almost complete inhibition of TEA uptake and Calu-3 cells (96.6 ± 7.3%) were not affected (Fig. 4e) . MPP + (1 mM) caused a strong reduction in TEA taken up by ATI-like (33.9 ± 14.8%), NCI-H441 (28.6 ± 9.8%) and Calu-3 (14.6 ± 6.5%) cells. In A549 cells, the effect of MPP + was even more pronounced, lowering TEA uptake to 4.5 ± 1.2% of control (Fig. 4d) . Verapamil (200 µM) was also a potent inhibitor in all four cell models, completely abolishing TEA uptake to 0.0 ± 0.4% and 0.0 ± 11.8% in A549 and NCI-H441 cells, respectively. TEA accumulation into ATI-like cells was somewhat less affected (15.7 ± 10.8%) as it was in Calu-3 cells (16.6 ± 2.3%) (Fig. 4f) .
In general, when comparing the pharmacological inhibition profiles in the three 
Discussion
Studying the contribution of membrane transporters to the (patho)physiology, pharmacokinetics and pharmacodynamics in a complex organ such as the lungs is a formidable task, and data generated in robust in vitro models are invaluable. Membrane transporters have been confirmed to be present throughout the different areas of lung mucosa (Gumbleton et al., 2011) , however, only a limited number of activity studies have been carried out in human pulmonary epithelial cells thus far. To worsen the situation, most studies have utilised dissimilar in vitro models (Horvath et al., 2007; Macdonald et al., 2013; Mukherjee et al., 2012; Salomon et al., 2012) . There is thus, an urgent demand for physiologically relevant and well-characterised in vitro models of human lung epithelium for studies of pulmonary solute transport, e.g. in the context of drug disposition.
In this work, we sought to determine OCT activity in a number of commonly OCT-mediated transport (Horvath et al., 2011; Macdonald et al., 2013; Salomon et al., 2012; Stachon et al., 1997) . However, ASP + is lacking specificity as an
OCT substrate in organotypic cell models that express a gamut of transporter types. The compound, e.g. is also a high affinity ligand of monoamine 15 transporter such as NET, DAT and SERT (). and K m values reported for ASP + in heterologous systems over-expressing monoamine transporters were about 1000-times lower than those measured in OCT transfectants (Nies et al., 2011; Haunsø and Buchanan, 2007; Mason et al., 2005; Oz et al., 2010) . Hence, in this study, TEA was used, which appears to be somewhat less promiscuous (Nies et al., 2011) . 
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RNAi studies in A549 cells resulted in significantly reduced TEA uptake activity when OCT1 and OCT2 were silenced, whereas knockdown of OCT3 had almost no effect. Regrettably, RNAi studies using primary alveolar epithelial cells did not produce meaningful data due to the high toxicity of the transfection reagent (data not shown).
As an alternative, pharmacological inhibitors were used to deconvolve and compare cation uptake pathways in the different cell types. ATI-like cells were least affected by amantadine (OCT1 and OCT2 inhibitor), whereas corticosterone, Dec-22, MPP + , quinidine and verapamil, which are all known to block all three OCT subtypes, showed inhibitory effects of 70-95% of TEA uptake (MPP + < corticosterone = Dec-22 < verapamil < quinidine).
OCT expression pattern determined by Western blot Salomon et al., 2014) and the now studied TEA uptake rate were quite similar in ATI-like and A549 cells. Nevertheless, were the highest number of significantly different pharmacological effects on TEA uptake observed when comparing the two cell types. ATI-like cells were generally less affected by the modulators than A549. It can thus, be hypothesised that organic cation transporters are either expressed at a lower level and/or on the basolateral membranes of the primary cells, which would make them less accessible for both substrates and inhibitors . Inhibition of TEA uptake into Calu-3 cells was also
significantly different from what was observed in ATI-like cells in the case of half of the pharmacological inhibitors studied; specifically, corticosterone, Dec-22
and quinidine proved to be less effective in Calu-3 than in primary alveolar epithelial cells. Moreover, TEA accumulation in Calu-3 was only a fraction of values measured in ATI-like cells. Recent studies have confirmed that OCT2 is 17 absent in Calu-3 cells (Macdonald et al., 2013; Mukherjee et al., 2012; Salomon et al., 2012) , suggesting that OCT1 might play a key role in translocating organic cations in this cell type.
When comparing data from ATI-like monolayers with those from NCI-H441 cells, it was noted that, albeit TEA uptake over time was lower in the cell line, there was only one outlier observed in the inhibitor studies (i.e. corticosterone).
Considering that expression patterns of OCT between the two cell types were very close when assessed with molecular biological techniques (Salomon et al., 2014) , NCl-H441 epithelial cells seem to exhibit profound similarities to primary cells in their spatial expression and organic cation transporter function.
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Conclusions
Uptake pathways for cations in A549 and Calu-3 cells and ATI-like cells are very different from each other, whereas a higher degree of similarity was observed between primary calls and the NCI-H441 cell line. Organic cation uptake at the lung epithelial barrier, nevertheless, very likely also involves other transporters not studied in this paper such as gene products encoded by SLC5, SLC6, SLC7, SLC29, SLC44 and SLC47. 
